NUREMBERG

TREKSTOR Donates 100.000 FFP2 Respirators to Tafel Deutschland e.V.

Retrieved on: 
Thursday, January 28, 2021

Today the TREKSTOR GmbH, the manufacturer behind the blnk branded healthcare products, completed delivery of 100.000 FFP2 class respirators to the Tafel Deutschland.

Key Points: 
  • Today the TREKSTOR GmbH, the manufacturer behind the blnk branded healthcare products, completed delivery of 100.000 FFP2 class respirators to the Tafel Deutschland.
  • View the full release here: https://www.businesswire.com/news/home/20210128005522/en/
    A volunteer at Tafel Bayern takes possession of and inspects the donated FFP2 respirators.
  • As do all FFP2 respirators, it filters 94% of particles, in the COVID-19 relevant comparison with NaCL, the masks even performed above the 99% mark.
  • The food banks are organized in the umbrella organization Tafel Deutschland e. V.
    View source version on businesswire.com: https://www.businesswire.com/news/home/20210128005522/en/

Amicus Therapeutics Announces Presentations and Posters at the 17th Annual WORLDSymposium™ 2021

Retrieved on: 
Thursday, January 21, 2021

CRANBURY, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases, today announced that three oral presentations and ten posters highlighting its development programs for Lysosomal Disorders will be included at the 17th Annual WORLDSymposium 2021 , to be held virtually February 8-12, 2021.

Key Points: 
  • CRANBURY, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases, today announced that three oral presentations and ten posters highlighting its development programs for Lysosomal Disorders will be included at the 17th Annual WORLDSymposium 2021 , to be held virtually February 8-12, 2021.
  • Each year, WORLDSymposiumhosts a scientific meeting presenting the latest information from basic science, translational research, and clinical trials for lysosomal diseases.
  • Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases.
  • With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases.

Global Hot Melt Adhesives Market to Surpass US$ 9.8 Billion by 2027, Owing to Rising Demands of Reactive Hot Melt Adhesives – Says Coherent Market Insights (CMI)

Retrieved on: 
Wednesday, January 20, 2021

The global hot melt adhesives market has witnessed rapid growth in terms of revenue in the past few years owing to the competitive advantages of hot melt adhesives over solvent-based & water-based adhesive types.

Key Points: 
  • The global hot melt adhesives market has witnessed rapid growth in terms of revenue in the past few years owing to the competitive advantages of hot melt adhesives over solvent-based & water-based adhesive types.
  • This is expected to fuel the growth of the global hot melt adhesives market during the forecast period.
  • The global hot melt adhesives market is expected to exhibit a CAGR of 5.2% during the forecast period (2020-2027).
  • The development of hydrophilic hot melt adhesives and polyamide hot melt adhesives is gaining interest in developed countries, which is driving growth of the hot melt adhesives market.

DGAP-News: 777 Capital Partners AG successfully started its activities in 2020 and acquired projects with a total volume of 100 million euros in Berlin-Mitte and near Nuremberg

Retrieved on: 
Monday, January 18, 2021

777 Capital Partners AG ( www.777capital.com ), a newly founded investment boutique for innovative, sustainable and high return real estate investments, has successfully completed the acquisition of its first two project developments.

Key Points: 
  • 777 Capital Partners AG ( www.777capital.com ), a newly founded investment boutique for innovative, sustainable and high return real estate investments, has successfully completed the acquisition of its first two project developments.
  • The value of the assets in Berlin-Mitte and in the greater Nuremberg area sums up to 100 million Euros.
  • The building permit for the development with a volume of around 65 million Euros has already been obtained.
  • I am pleased that we were able to acquire such promising projects just a few weeks after the launch of 777 Capital.

Allot Introduces DNS Secure to Expand its Mass-market Security Portfolio

Retrieved on: 
Monday, January 11, 2021

Our solutions are deployed globally for network and application analytics, traffic control and shaping, network-based security services, and more.

Key Points: 
  • Our solutions are deployed globally for network and application analytics, traffic control and shaping, network-based security services, and more.
  • Our industry-leading network-based security as a service solution has achieved over 50% penetration with some service providers and is already used by over 20 million subscribers globally.
  • Open-Xchange (OX) is a developer of secure and open communication and office productivity software, IMAP server software and DNS solutions.
  • OX Dovecot is the worlds most popular IMAP server software and OX PowerDNS provides secure DNS services to telco customers and their users worldwide.

DGAP-News: Energiekontor sells Höttingen solar park to 7C Solarparken

Retrieved on: 
Wednesday, December 30, 2020

Energiekontor AG has sold the Httingen solar park with a total output of around 8.3 MW to 7C Solarparken AG.

Key Points: 
  • Energiekontor AG has sold the Httingen solar park with a total output of around 8.3 MW to 7C Solarparken AG.
  • The Httingen solar park had successfully participated in the EEG tender of 1.12.2019 and thus secured the relatively attractive remuneration of the tender date at that time.
  • Peter Szabo, CEO of Energiekontor AG, is satisfied: "The sales process for the solar park was conducted in a partnership-based, professional and highly efficient manner.
  • Steven De Proost, CEO of 7C Solarparken AG, comments: "With the purchase of the Httingen solar park, we are increasing our IPP portfolio to 265 MWp.